Electrophoretic Mobility Shift Assay
"Electrophoretic Mobility Shift Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An electrophoretic technique for assaying the binding of one compound to another. Typically one compound is labeled to follow its mobility during electrophoresis. If the labeled compound is bound by the other compound, then the mobility of the labeled compound through the electrophoretic medium will be retarded.
| Descriptor ID |
D024202
|
| MeSH Number(s) |
E05.196.401.500
|
| Concept/Terms |
Electrophoretic Mobility Shift Assay- Electrophoretic Mobility Shift Assay
- EMSA Electrophoretic Technique
- EMSA Electrophoretic Techniques
- Electrophoretic Technique, EMSA
- Electrophoretic Techniques, EMSA
- Technique, EMSA Electrophoretic
- Techniques, EMSA Electrophoretic
- Band Shift Mobility Assay
- Mobility Shift Assay
- Assay, Mobility Shift
- Assays, Mobility Shift
- Mobility Shift Assays
- Bandshift Mobility Assay
- Assay, Bandshift Mobility
- Assays, Bandshift Mobility
- Bandshift Mobility Assays
- Mobility Assay, Bandshift
- Mobility Assays, Bandshift
Supershift Mobility Assay- Supershift Mobility Assay
- Assay, Supershift Mobility
- Assays, Supershift Mobility
- Mobility Assay, Supershift
- Mobility Assays, Supershift
- Supershift Mobility Assays
Gel Shift Analysis- Gel Shift Analysis
- Analyses, Gel Shift
- Analysis, Gel Shift
- Gel Shift Analyses
- Gelshift Analysis
- Gel Retardation Assay
- Assay, Gel Retardation
- Assays, Gel Retardation
- Gel Retardation Assays
|
Below are MeSH descriptors whose meaning is more general than "Electrophoretic Mobility Shift Assay".
Below are MeSH descriptors whose meaning is more specific than "Electrophoretic Mobility Shift Assay".
This graph shows the total number of publications written about "Electrophoretic Mobility Shift Assay" by people in this website by year, and whether "Electrophoretic Mobility Shift Assay" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 3 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 5 | 5 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Electrophoretic Mobility Shift Assay" by people in Profiles.
-
Identification of Proteins Interacting with Single Nucleotide Polymorphisms (SNPs) by DNA Pull-Down Assay. Methods Mol Biol. 2019; 1855:355-362.
-
A Rare Variant (rs933717) at FBXO31-MAP1LC3B in Chinese Is Associated With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2018 02; 70(2):287-297.
-
Crystal structure and DNA binding activity of a PadR family transcription regulator from hypervirulent Clostridium difficile R20291. BMC Microbiol. 2016 Oct 04; 16(1):231.
-
Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. Am J Hum Genet. 2014 Apr 03; 94(4):586-98.
-
The tumor suppressor Kruppel-like factor 6 is a novel aryl hydrocarbon receptor DNA binding partner. J Pharmacol Exp Ther. 2013 Jun; 345(3):419-29.
-
Molecular basis of 'hypoxic' breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling. Radiat Oncol. 2013 Mar 04; 8:46.
-
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells. Oncol Rep. 2013 Jan; 29(1):306-14.
-
RBPJ mutations identified in two families affected by Adams-Oliver syndrome. Am J Hum Genet. 2012 Aug 10; 91(2):391-5.
-
Growth phase-dependent modulation of Rgg binding specificity in Streptococcus pyogenes. J Bacteriol. 2012 Aug; 194(15):3961-71.
-
The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production. Mol Immunol. 2011 Oct; 49(1-2):367-79.